Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Bushu Pharmaceuticals Ltd.
483
•Bushu Pharmaceuticals Ltd.•December 2, 2022

Bushu Pharmaceuticals Ltd. – FDA 483, Dec 2, 2022

Record Details

This FDA Form 483 document details observations from an inspection, highlighting deficiencies in quality control and facility management.

**Observation 1** addresses the quality control unit's responsibilities and procedures not being fully written or followed. Specifically: * Complaint records for on-site investigations (Procedure 141.0-QA) are incomplete, lacking full documentation or justification for reported actions. Evaluation of retention samples is not fully described (e.g., quantity, inspection steps, timeliness). Complaints citing "Lack of Efficacy" (e.g., "b) <4) -l Tabs~~ mg CHK2003-004 /2003-005") only included visual inspection, not analytical testing. * Deviation reports (Procedure 1B7.0QA) are not always fully documented to support conclusions or "no further actions." For instance, Deviation report DVK210238 (16Dec2021) for failed disintegration tests in "b) <4) mg Lot fbl < )7 and fbl < )7" (results NMTl min) resulted in no additional actions after an evaluation, and both lots were released.

**Observation 3** identifies deficiencies in separate or defined areas and control systems to prevent contamination or mix-ups. Specifically: * Records of abnormal events in Manufacturing Building [redacted] (SOP 411

Company
Bushu Pharmaceuticals Ltd.
Inspection date
December 2, 2022
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Noreen Muniz (Investigator)
View Company Profile

ID · 47c2fcd8-6261-4cbd-a7fb-ee65aeee4c88

Other documents for Bushu Pharmaceuticals Ltd.
  • 483 - 2026-08-03August 3, 2026
  • 483 - 2022-12-02December 2, 2022

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bushu Pharmaceuticals Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.